recombinant human collagen vaginal gel

Recombinant human collagen vaginal gel is a topical biologic therapy developed for the treatment of vaginal dryness and vaginal atrophy, particularly in postmenopausal women. The product utilizes recombinant DNA technology to produce human-like collagen, which serves to restore the structural integrity and moisture-retaining capacity of the vaginal mucosa. By replenishing the extracellular matrix, it aims to alleviate symptoms of genitourinary syndrome of menopause (GSM). Clinical evaluation has been conducted in China, comparing its efficacy and safety to hyaluronic acid-based gels.

Other names

recombinant human collagenrecombinant humanized collagen